Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Inc. (BCAX) is a healthcare company (biotechnology) based in the United States. The share price is $9.58, down 1.74% on the day, which values the company at $635.99M. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$9.58−1.74% today
Market value
$635.99M
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Bicara Therapeutics Inc. in more detail

BCAX trades at -2.5× next year's expected earnings.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Debt is growing faster than cash flow.

1 of the superinvestors tracked here hold BCAX, including Peter Kolchinsky (1.9% of the portfolio).

Superinvestors holding BCAX

1 of the investors tracked here report a position in their latest 13F filing.

Bicara Therapeutics Inc. (BCAX): questions and answers

What is Bicara Therapeutics Inc.'s market cap?

Bicara Therapeutics Inc. is valued at $635.99M at a share price of $9.58.

Does BCAX pay a dividend?

Bicara Therapeutics Inc. does not currently pay a regular dividend.

Which famous investors own BCAX?

In their latest quarterly filings, Peter Kolchinsky (1.9% of the portfolio) hold BCAX. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Bicara Therapeutics Inc. (BCAX) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BCAX

Underlying data: Yahoo Finance; company filings with the SEC.